LAPTM5 and renal cell carcinoma: In addition, primary RCC tissues of patients with lung metastases displayed higher LAPTM5 levels than those without lung metastases but lower LAPTM5 levels than lung metastases tissues (Fig. 7e and Supplementary Fig. 9e).